StockData
Acadia Pharmaceuticals Inc logo

Acadia Pharmaceuticals Inc (ACAD) stock

ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3027% below fair value
$18.32−0.35 (-1.87%)

Close on Nov 17, 2026Market cap $3.16BP/E 8.3Yield –

Acadia Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Acadia Pharmaceuticals's market cap was $3.16B on Nov 11, 2026, against $4.24B a year earlier. Over the last 5 years it ranged from $2.27B to $5.13B, with a median of $3.54B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.16B-30.0%
2025Dec 31, 2025$4.52B+48.0%
2024Dec 31, 2024$3.05B-40.5%
2023Dec 29, 2023$5.13B+99.2%
2022Dec 30, 2022$2.58B-31.3%
2021Dec 31, 2021$3.75B-55.8%
2020Dec 31, 2020$8.49B+29.3%
2019Dec 31, 2019$6.57B+224.9%
2018Dec 31, 2018$2.02B-45.3%
2017Dec 29, 2017$3.70B+5.8%
2016Dec 30, 2016$3.49B-2.9%
2015Dec 31, 2015$3.60B+13.6%
2014Dec 31, 2014$3.17B+42.4%
2013Dec 31, 2013$2.22B+745.0%
2012Dec 31, 2012$263.14M+361.4%
2011Dec 30, 2011$57.02M+26.8%
2010Dec 31, 2010$44.97M–

More Acadia Pharmaceuticals figures

See a number that looks wrong?